Kevin L. Keim

Kevin L. Keim

Director/Miembro de la Junta en NeuroMedix, Inc. .

Health Technology
Consumer Services
Commercial Services

Perfil

Kevin L.
Keim
is currently the Director at NeuroMedix, Inc., Director at American Society of Experimental Neurotherapeutics, Chief Development Officer at Syneos Health NC LLC, and Trustee at Ravenscroft School, Inc. Previously, he was the President & Chief Executive Officer at Vela Pharmaceuticals, Inc. from 2000 to 2013.
He also held positions as Director at Clinilabs, Inc., Principal at Wyeth LLC, President at Quintiles Pacific, Inc., and Principal at Hoffmann-La Roche, Inc. Keim received his undergraduate degree from Delaware Valley University, graduate degree from Fairleigh Dickinson University, and doctorate from New York University.

Cargos activos de Kevin L. Keim

EmpresasCargoInicio
Corporate Officer/Principal -
American Society of Experimental Neurotherapeutics Director/Miembro de la Junta -
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Todos los cargos activos de Kevin L. Keim

Antiguos cargos conocidos de Kevin L. Keim.

EmpresasCargoFin
Director Ejecutivo 13/11/2013
Director/Miembro de la Junta -
Corporate Officer/Principal -
Corporate Officer/Principal -
Presidente -
Ver el detalle de la experiencia de Kevin L. Keim.

Formación de Kevin L. Keim.

Delaware Valley University Undergraduate Degree
Fairleigh Dickinson University Graduate Degree
New York University Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Kevin L. Keim.

Relaciones

57

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas9

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

American Society of Experimental Neurotherapeutics

Commercial Services

Consumer Services

Ver las conexiones de la empresa
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA